TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Mitchell Haut, MD

Mercy Cancer Center at Mercy ...


Canton, Ohio - 44708 (330-453-9993)
  • CLINICAL TRIALS 27
  • CONDITIONS35
  • INTERVENTIONS60
  • SINCE1991
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

June 2008 - December 2009
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer

November 2003 - June 2012
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer

June 2007 - April 2012
Zoledronate Vitamin D and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer Lung Cancer or Breast Cancer

July 2006 - March 2013
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer

October 2008 - October 2010
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

August 2008 - August 2013
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

April 2009 - April 2010
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer

March 2009 - January 2014
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II Stage III or Stage IV Ovarian Epithelial Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer

August 2009 - January 2016
Melphalan Prednisone and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

February 2008 - August 2009
Paclitaxel Cisplatin and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

June 2008 - December 2015
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer

October 2005 - February 2008
Paclitaxel Carboplatin and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

March 2010 - December 2010
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

July 1991 -
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer

July 2005 - July 2012
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

April 1999 -
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

September 2007 - May 2012
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer

July 2009 - December 2010
Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

July 2004 -
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

June 2007 - January 2010
Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

September 2009 - January 2011
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

July 2009 - August 2011
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

March 2010 - January 2020
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
Carboplatin Paclitaxel and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer

January 2010 - July 2012
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Nervous System Neoplasms

Central Nervous System Neoplasms

Lymphoma

Adenocarcinoma

Prostatic Neoplasms

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Neoplasms

Neoplasm Metastasis

Myelodysplastic Syndromes

Preleukemia

Ovarian Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Kidney Neoplasms

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Esophageal Diseases

Esophageal Neoplasms

Peritoneal Neoplasms

Fallopian Tube Neoplasms

Glioblastoma

Carcinoma, Small Cell

Precancerous Conditions

Myeloproliferative Disorders

Colorectal Neoplasms

Carcinoma, Transitional Cell

Hematologic Neoplasms

Ureteral Neoplasms

Urologic Neoplasms

Urethral Neoplasms

Placebo

Melphalan

Immunohistochemistry Staining Method

Laboratory Biomarker Analysis

Zoledronic Acid

Study Of Socioeconomic And Demographic Variables

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Erlotinib Hydrochloride

Gemcitabine Hydrochloride

Gene Expression Analysis

Polymorphism Analysis

Cyclophosphamide

Prednisone

Radiation Therapy

Lenalidomide

Pemetrexed Disodium

Temozolomide

Oxaliplatin

Doxorubicin Hydrochloride

Temsirolimus

Polymerase Chain Reaction

Sunitinib Malate

Vitamin D

Trastuzumab

Cixutumumab

Sorafenib Tosylate

Thalidomide

Fluorescence In Situ Hybridization

Rosuvastatin

Mutation Analysis

Cetuximab

Biologic Sample Preservation Procedure

Study Of High Risk Factors

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry

Calcium Carbonate

Irinotecan Hydrochloride

Etoposide Phosphate

Ixabepilone

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Ac Regimen

Cytogenetic Analysis

Therapeutic Thoracoscopy

Videothoracoscopy

Hedgehog Antagonist Gdc-0449

Calcium Citrate

Calcium Glucarate

Calcium Gluconate

Samarium Sm 153 Lexidronam Pentasodium

Strontium Chloride Sr 89

Vinorelbine Ditartrate

Standard Follow-Up Care

Placebo Administration

Chromogenic In Situ Hybridization

Fluorescent Antibody Technique

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo